20,000
Participants
Start Date
March 27, 2024
Primary Completion Date
March 27, 2026
Study Completion Date
March 27, 2030
AI-enabled quantitative coronary plaque analysis (AI-QCPA)
The HeartFlow Plaque Analysis provides plaque identification, quantification, and characterization and is meant to support qualified clinicians to aid in the evaluation and risk assessment of coronary artery disease (CAD). It provides data on the volume and type of plaque present (Calcified, Non-calcified, Low Attenuation), both vessel specific and total volumes, with which physicians can better understand a patient's risk, discuss heart health, and help optimize medical management. Plaque Analysis is calculated using image data from a previously acquired CCTA.
Moses Cone Memorial Hospital, Greensboro
Lead Sponsor
HeartFlow, Inc.
INDUSTRY